TrialJournal of clinical psychopharmacology

Opioid Receptor μ-1 and Ketamine Effects in a Suicidal Depression Trial: A Post Hoc Exploration.

Michael F Grunebaum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.